Los administradores de TransicionEstructural no se responsabilizan de las opiniones vertidas por los usuarios del foro. Cada usuario asume la responsabilidad de los comentarios publicados.
0 Usuarios y 2 Visitantes están viendo este tema.
Cita de: Lurker en Julio 16, 2020, 22:18:17 pmSobre UK, he encontrado esto:https://www.dailymail.co.uk/news/article-8529269/amp/Daily-death-toll-INFLATED-fewer-40-people-dying-day-UK.html?__twitter_impression=true"They said PHE's figures 'vary substantially from day to day' and explained: 'This variation is most likely due to the appearance of "historic" deaths that have occurred weeks before, but for some reason unknown to us, get reported in batches on particular days."Y esto:https://www.cebm.net/covid-19/why-no-one-can-ever-recover-from-covid-19-in-england-a-statistical-anomaly/"Here, it seems that PHE regularly looks for people on the NHS database who have ever tested positive, and simply checks to see if they are still alive or not. PHE does not appear to consider how long ago the COVID test result was, nor whether the person has been successfully treated in hospital and discharged to the community. Anyone who has tested COVID positive but subsequently died at a later date of any cause will be included on the PHE COVID death figures."Sds.Puede ser - Pero en UK la variación diaria durante una semana es grande pero enteramente predecible, el fin de semana prácticament nadie da datos, y el lunes y martes se acumulan El segundo link tiene pinta de ser verdad, porque el exceso de muertes publicado por la ONS que es el instituto de estadistica dice que desde hace un mes o así hay menos muertos que los que corresponderíá proyectando las cifras del pasado y ajustandolas por cambios demográficos y de esperanza de vida
Sobre UK, he encontrado esto:https://www.dailymail.co.uk/news/article-8529269/amp/Daily-death-toll-INFLATED-fewer-40-people-dying-day-UK.html?__twitter_impression=true"They said PHE's figures 'vary substantially from day to day' and explained: 'This variation is most likely due to the appearance of "historic" deaths that have occurred weeks before, but for some reason unknown to us, get reported in batches on particular days."Y esto:https://www.cebm.net/covid-19/why-no-one-can-ever-recover-from-covid-19-in-england-a-statistical-anomaly/"Here, it seems that PHE regularly looks for people on the NHS database who have ever tested positive, and simply checks to see if they are still alive or not. PHE does not appear to consider how long ago the COVID test result was, nor whether the person has been successfully treated in hospital and discharged to the community. Anyone who has tested COVID positive but subsequently died at a later date of any cause will be included on the PHE COVID death figures."Sds.
Cita de: Maloserá en Julio 16, 2020, 20:32:17 pmCita de: uno en Julio 16, 2020, 19:42:32 pmEstuvieron unos días sin actualizar pero ahora ya lo hacen de nuevo cada día. El de 7 días creo que es el más fiable ya que los casos en 24 horas (que es lo que publican los medios) no es real. La gráfica la hacen a partir del informe diario oficial que se publica aquí Gracias. Estaba buscando justo esos datos. Yo estaba comparando lo que publica cada día El País con https://www.worldometers.info/coronavirus/Y me llamaba la atención que UK estaba teniendo menos contagios diarios haciendo casi el doble de tests, y en cambio la información diaria nacional era que habíá menos de un centenar de casos. No entiendo como aún en UK siguen muriendo unos 50-70 diarios haciendo media semanal, y ahí uno o dos. Será que en UK se siguen contagiando en residencias de ancianos?La vitamina D?, El sol?(Recordemos la anomalía en las horas de sol que sufrió el sur de Europa durante el lockdown)
Cita de: uno en Julio 16, 2020, 19:42:32 pmEstuvieron unos días sin actualizar pero ahora ya lo hacen de nuevo cada día. El de 7 días creo que es el más fiable ya que los casos en 24 horas (que es lo que publican los medios) no es real. La gráfica la hacen a partir del informe diario oficial que se publica aquí Gracias. Estaba buscando justo esos datos. Yo estaba comparando lo que publica cada día El País con https://www.worldometers.info/coronavirus/Y me llamaba la atención que UK estaba teniendo menos contagios diarios haciendo casi el doble de tests, y en cambio la información diaria nacional era que habíá menos de un centenar de casos. No entiendo como aún en UK siguen muriendo unos 50-70 diarios haciendo media semanal, y ahí uno o dos. Será que en UK se siguen contagiando en residencias de ancianos?
Estuvieron unos días sin actualizar pero ahora ya lo hacen de nuevo cada día. El de 7 días creo que es el más fiable ya que los casos en 24 horas (que es lo que publican los medios) no es real. La gráfica la hacen a partir del informe diario oficial que se publica aquí
La anomalía fue precisamente el lockdown, cero horas de sol para la mayoría del pueblo español.
Cita de: hispanic_exodus en Julio 17, 2020, 07:43:45 amLa anomalía fue precisamente el lockdown, cero horas de sol para la mayoría del pueblo español.El tema es que por algún motivo, dietético o lo que sea, en España (y creo que Italia también) viene siendo endémico que la gente tenga déficit de vitamina D. He visto alguna charla donde creo que se relacionaba también con el uso de cremas solares y otros cosméticos, posiblemente por la presencia de disruptores endocrinos (también presentes en plásticos de uso alimentario, etc).El lockdown obviamente empeoró algo las cosas, pero es que además si hubo menos horas de sol, pues hubiera seguido siendo peor. Por otra parte, parece que la vitamina D protege si tienes los niveles bien *antes* del contagio, pero una vez contagiado no parece que sirva de mucho suplementarla al enfermo.Yo por si acaso he estado hasta que llegó el verano comiendo bastante salmón e hígado de bacalao, y comprando leche enriquecida en vit.D (aunque según algunas fuentes, las dosis recomendables para garantizar niveles saludables son más altas de las que vienen normalmente en la leche enriquecida, pero algo es algo).Siento no poner las fuentes, cuando tenga un rato las busco.
Cita de: Maloserá en Julio 16, 2020, 22:41:11 pmCita de: Lurker en Julio 16, 2020, 22:18:17 pmSobre UK, he encontrado esto:https://www.dailymail.co.uk/news/article-8529269/amp/Daily-death-toll-INFLATED-fewer-40-people-dying-day-UK.html?__twitter_impression=true"They said PHE's figures 'vary substantially from day to day' and explained: 'This variation is most likely due to the appearance of "historic" deaths that have occurred weeks before, but for some reason unknown to us, get reported in batches on particular days."Y esto:https://www.cebm.net/covid-19/why-no-one-can-ever-recover-from-covid-19-in-england-a-statistical-anomaly/"Here, it seems that PHE regularly looks for people on the NHS database who have ever tested positive, and simply checks to see if they are still alive or not. PHE does not appear to consider how long ago the COVID test result was, nor whether the person has been successfully treated in hospital and discharged to the community. Anyone who has tested COVID positive but subsequently died at a later date of any cause will be included on the PHE COVID death figures."Sds.Puede ser - Pero en UK la variación diaria durante una semana es grande pero enteramente predecible, el fin de semana prácticament nadie da datos, y el lunes y martes se acumulan El segundo link tiene pinta de ser verdad, porque el exceso de muertes publicado por la ONS que es el instituto de estadistica dice que desde hace un mes o así hay menos muertos que los que corresponderíá proyectando las cifras del pasado y ajustandolas por cambios demográficos y de esperanza de vidaYo sospecho lo mismo. Además, en Leicester hay sospechas, no tengo claro hasta qué punto son infundadas, de que hay un doble conteo en los casos de positivos.https://www.google.com/amp/s/www.leicestermercury.co.uk/news/leicester-news/what-government-says-claims-positive-4305861.amp
¿Especialmente en residencias y personas mayores que viven solas? Cabría, además, poder conocer el grado de malnutrición que existe en algunos de esos centros.
¿Cómo de cerca estamos de un rebrote?https://www.elconfidencial.com/tecnologia/ciencia/2020-07-18/covid-19-rebrotes-provincias_2685656/
https://www.zerohedge.com/markets/gilead-will-charge-more-3000-course-remdesivirCitarAll those stories about patients being billed for tens of thousands of dollars for coronavirus-related care elicited promises from the White House that "everything will be covered". Still, as thousands of Americans complain about charges related to COVID-19 testing and care being passed on by their insurance companies, Gilead, the pharmaceutical company that has pushed remdesivir down the world's throat despite the fact that the cheap steroid dexamethasone has proven - in at least one high quality study - more effective at lowering mortality rates, has just published its expected pricetag for a five-dose course of the drug.On Monday, Gilead disclosed its pricing plan for Gilead as it prepares to begin charging for the drug at the beginning of next month (several international governments have already placed orders). Given the high demand, thanks in part due to the breathless media coverage despite the drug's still-questionable study data, Gilead apparently feels justified in charging $3,120 for a patient getting the shorter, more common, treatment course, and $5,720 for the longer course for more seriously ill patients. These are the prices for patients with commercial insurance in the US, according to Gilead's official pricing plan.As per usual, the price charged to those on government plans will be lower, and hospitals will also receive a slight discount. Additionally, the US is the only developed country where Gilead will charge two prices, according to Gilead CEO Daniel O’Day. In much of Europe and Canada, governments negotiate drug prices directly with drugmakers (in the US, laws dictate that drug makers must "discount" their drugs for medicare and medicaid plans).But according to O'Day, the drug is priced "far below the value it brings" to the health-care system.However, we'd argue that this actually isn't true. Remdesivir was developed by Gilead to treat Ebola, but the drug was never approved by the FDA for this use, which caused Gilead to shelve the drug until COVID-19 presented another opportunity. Even before the first study had finished, the company was already pushing propaganda about the promising nature of the drug. Meanwhile, the CDC, WHO and other organizations were raising doubts about the effectiveness of steroid medications.Months later, the only study on the steroid dexomethasone, a cheap steroid that costs less than $50 for a 100-dose regimen, has shown that dexomethasone is the only drug so far that has proven effective at lowering COVID-19 related mortality. Remdesivir, despite the fact that it has been tested in several high quality trials, has not.So, why is the American government in partnership with Gilead still pushing this questionable, and staggeringly expensive, medication on the public?
All those stories about patients being billed for tens of thousands of dollars for coronavirus-related care elicited promises from the White House that "everything will be covered". Still, as thousands of Americans complain about charges related to COVID-19 testing and care being passed on by their insurance companies, Gilead, the pharmaceutical company that has pushed remdesivir down the world's throat despite the fact that the cheap steroid dexamethasone has proven - in at least one high quality study - more effective at lowering mortality rates, has just published its expected pricetag for a five-dose course of the drug.On Monday, Gilead disclosed its pricing plan for Gilead as it prepares to begin charging for the drug at the beginning of next month (several international governments have already placed orders). Given the high demand, thanks in part due to the breathless media coverage despite the drug's still-questionable study data, Gilead apparently feels justified in charging $3,120 for a patient getting the shorter, more common, treatment course, and $5,720 for the longer course for more seriously ill patients. These are the prices for patients with commercial insurance in the US, according to Gilead's official pricing plan.As per usual, the price charged to those on government plans will be lower, and hospitals will also receive a slight discount. Additionally, the US is the only developed country where Gilead will charge two prices, according to Gilead CEO Daniel O’Day. In much of Europe and Canada, governments negotiate drug prices directly with drugmakers (in the US, laws dictate that drug makers must "discount" their drugs for medicare and medicaid plans).But according to O'Day, the drug is priced "far below the value it brings" to the health-care system.However, we'd argue that this actually isn't true. Remdesivir was developed by Gilead to treat Ebola, but the drug was never approved by the FDA for this use, which caused Gilead to shelve the drug until COVID-19 presented another opportunity. Even before the first study had finished, the company was already pushing propaganda about the promising nature of the drug. Meanwhile, the CDC, WHO and other organizations were raising doubts about the effectiveness of steroid medications.Months later, the only study on the steroid dexomethasone, a cheap steroid that costs less than $50 for a 100-dose regimen, has shown that dexomethasone is the only drug so far that has proven effective at lowering COVID-19 related mortality. Remdesivir, despite the fact that it has been tested in several high quality trials, has not.So, why is the American government in partnership with Gilead still pushing this questionable, and staggeringly expensive, medication on the public?